About WuXi Biologics
WuXi Biologics is a company based in Shanghai (China) founded in 2008.. The company has 12,570 employees as of December 31, 2024. WuXi Biologics has completed 1 acquisition, including CMAB Biopharma. WuXi Biologics operates in a competitive market with competitors including Novartis, Catalent, Surrozen, Biotage and Curia, among others.
- Headquarter Shanghai, China
- Employees 12570 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Wuxi Biologics (Cayman) Inc.
-
Annual Revenue
$2.61 B (USD)7.57as on Dec 31, 2024
-
Net Profit
$468.68 M (USD)-3.14as on Dec 31, 2024
-
EBITDA
$871.69 M (USD)15.21as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
12570
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of WuXi Biologics
WuXi Biologics is a publicly listed company on the HKEX with ticker symbol 2269 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Software Development Team
70 people
Leadership Team
44 people
Senior Team
24 people
Product Management Team
22 people
Human Resources and Administration
13 people
QC Team
10 people
Finance and Accounting
6 people
MSAT Team
4 people
Unlock access to complete
Funding Insights of WuXi Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by WuXi Biologics
WuXi Biologics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CMAB Biopharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biologic products are developed and manufactured for clinical stages.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - WuXi Biologics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Wuxi Biologics Comparisons
Competitors of WuXi Biologics
WuXi Biologics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novartis, Catalent, Surrozen, Biotage and Curia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
R&D focused on manufacturing of drugs for multiple therapeutic areas
|
|
| domain | founded_year | HQ Location |
CDMO offering drug and biologics development services
|
|
| domain | founded_year | HQ Location |
Selective Wnt agonists are developed for human tissue regeneration.
|
|
| domain | founded_year | HQ Location |
Organic synthesis, analytical, and peptide chemistry services for drug discovery and development
|
|
| domain | founded_year | HQ Location |
Drug research, development, testing, and consulting services are provided.
|
|
| domain | founded_year | HQ Location |
Provides contract research, development, and manufacturing services for biologic drugs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Wuxi Biologics
Frequently Asked Questions about WuXi Biologics
When was WuXi Biologics founded?
WuXi Biologics was founded in 2008.
Where is WuXi Biologics located?
WuXi Biologics is headquartered in Shanghai, China.
How many employees does WuXi Biologics have?
As of Dec 31, 2024, the latest employee count at WuXi Biologics is 12,570.
What is the annual revenue of WuXi Biologics?
Annual revenue of WuXi Biologics is $2.61B as on Dec 31, 2024.
What does WuXi Biologics do?
WuXi Biologics was founded in 2008 and is headquartered in Shanghai, China. Operations focus on the biologics sector, where protein therapeutics are developed and manufactured for global clients. Services include end-to-end solutions from research to production. In 2022, annual revenues of 2.27 billion were recorded, alongside a net profit of 0.66 billion. The domain wuxibiologics.com supports its online presence.
Who are the top competitors of WuXi Biologics?
Is WuXi Biologics publicly traded?
Yes, WuXi Biologics is publicly traded on HKEX under the ticker symbol 2269.
How many acquisitions has WuXi Biologics made?
WuXi Biologics has made 1 acquisition, including CMAB Biopharma.
What is WuXi Biologics's ticker symbol?
The ticker symbol of WuXi Biologics is 2269 on HKEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.